Sunshine Biopharma (SBFMW) Revenue Growth (3y) (2021 - 2026)
Sunshine Biopharma (SBFMW) Revenue Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 2.84% |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 4.19% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 15.52% |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 24.66% |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 2.94% |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -48.41% |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 7.85% |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 209.24% |
| 10 | Sunshine Biopharma | - | - | 2.18 Mn | 18.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.23% |
| Dec 31, 2025 | 29.60% |
| Sep 30, 2025 | 313.90% |
| Jun 30, 2025 | 297.08% |
| Mar 31, 2025 | 317.13% |
| Dec 31, 2024 | 383.07% |
| Sep 30, 2024 | 451.18% |
| Jun 30, 2024 | 460.35% |
| Mar 31, 2024 | 473.12% |
| Dec 31, 2023 | 549.64% |
| Sep 30, 2023 | 602.97% |
| Jun 30, 2023 | 616.07% |
| Mar 31, 2023 | 661.07% |
| Dec 31, 2022 | 619.99% |
| Sep 30, 2022 | 162.70% |
| Jun 30, 2022 | 267.31% |
| Mar 31, 2022 | 741.25% |
| Mar 31, 2021 | -23.98% |